# Ascent Pharmaceuticals Inc - Inspection Records

Source: https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593

> Inspection records and compliance data for Ascent Pharmaceuticals Inc in Central Islip, New York. Access full analysis and detailed observations.

---

## Details

- Name: Ascent Pharmaceuticals Inc
- FEI Number: 3009518416
- City: Central Islip
- State: New York
- Country Name: United States
- Address Line 1: 400 S Technology Dr
- Zip Code: 11722
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK, REPACK

## Related Documents

- [FDA Inspection 1261247 - Ascent Pharmaceuticals Inc - 2025-02-03](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/c809c793-a2a4-4d29-b653-366bab81e064) — source: FDA, date: February 3, 2025
- [483 - Ascent Pharmaceuticals Inc - 2024-08-09](https://www.keypedia.com/records/483/ascent-pharmaceuticals-inc/5433c7fb-c1b6-4241-b172-0cefbf262c27) — source: FDA, date: August 9, 2024
- [483 - Ascent Pharmaceuticals Inc - 2024-08-09](https://www.keypedia.com/records/483/ascent-pharmaceuticals-inc/b4c3eb9d-fc43-485b-92aa-b15585f5b691) — source: FDA, date: August 9, 2024
- [FDA Inspection 1229681 - Ascent Pharmaceuticals Inc - 2024-08-09](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/785fdfa2-0ee5-481f-9676-6caf1c676d33) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 9, 2024
- [FDA Inspection 1229681 - Ascent Pharmaceuticals Inc - 2024-08-09](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/ad54fbcb-6020-4316-b662-c5582cc31d0d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 9, 2024
- [EIR - Ascent Pharmaceuticals Inc - 2022-09-15](https://www.keypedia.com/records/eir/ascent-pharmaceuticals-inc/2fb010b3-445b-435d-a436-65bc3ad95991) — source: FDA, date: September 15, 2022
- [483 - Ascent Pharmaceuticals Inc - 2022-09-15](https://www.keypedia.com/records/483/ascent-pharmaceuticals-inc/2e23b981-2208-442a-b00c-5dea4a7b4772) — source: FDA, date: September 15, 2022
- [FDA Inspection 1179615 - Ascent Pharmaceuticals Inc - 2022-09-15](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/23ea7cb5-85bb-4ee6-96ce-1106d4aec03b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 15, 2022
- [EIR - Ascent Pharmaceuticals Inc - 2020-10-13](https://www.keypedia.com/records/eir/ascent-pharmaceuticals-inc/3eaf2db1-5d5f-47da-9d2e-06c2a5c8b70b) — source: FDA, date: October 13, 2020
- [483 - Ascent Pharmaceuticals Inc - 2020-10-13](https://www.keypedia.com/records/483/ascent-pharmaceuticals-inc/b3e18f47-8ed5-4369-97a2-52cd5886bfa7) — source: FDA, date: October 13, 2020
- [FDA Inspection 1132410 - Ascent Pharmaceuticals Inc - 2020-10-13](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/2cafc3cb-16db-4e60-997f-df0b11b87a48) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 13, 2020
- [EIR - Ascent Pharmaceuticals Inc - 2018-11-07](https://www.keypedia.com/records/eir/ascent-pharmaceuticals-inc/bf03bde7-3589-4d60-bff6-b421b9fbb1b2) — source: FDA, date: November 7, 2018
- [FDA Inspection 1074882 - Ascent Pharmaceuticals Inc - 2018-11-07](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/b6df4373-5d5c-4445-88c2-715ab5b7de63) — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2018
- [FDA Inspection 1067030 - Ascent Pharmaceuticals Inc - 2018-07-27](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/9cf4d629-afe2-4c60-b178-4dbf4b73f2f4) — classification: No Action Indicated (NAI), source: FDA, date: July 27, 2018
- [EIR - Ascent Pharmaceuticals Inc - 2018-02-21](https://www.keypedia.com/records/eir/ascent-pharmaceuticals-inc/08fb764b-023a-4f94-b7fa-d8d8c7e29daf) — source: FDA, date: February 21, 2018
- [FDA Inspection 1047500 - Ascent Pharmaceuticals Inc - 2018-02-21](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/23bc0b8c-a486-4678-85b0-8542dde6c892) — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2018
- [FDA Inspection 949174 - Ascent Pharmaceuticals Inc - 2015-11-09](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/c749f2b5-2da8-4100-aa42-ccc8c5bf3c8d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2015
- [FDA Inspection 852064 - Ascent Pharmaceuticals Inc - 2013-09-26](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/357d3b44-3de0-447f-ad5e-4eb4aba15b06) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2013

## Related Companies

- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [Kenvue Brands LLC](https://www.keypedia.com/companies/kenvue-brands-llc/69c27fd1-bbb9-4c3a-bbb5-4ac86be8e574)
- [NATCO Pharma Limited](https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a)
- [Emcure Pharmaceuticals Limited](https://www.keypedia.com/companies/emcure-pharmaceuticals-limited/d1295106-bf79-46f5-bf51-08338508f98e)
- [Rechon Life Science AB](https://www.keypedia.com/companies/rechon-life-science-ab/ce84eed4-ada6-40a0-9005-2c2d6bbd729d)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [Nephron Sc Inc](https://www.keypedia.com/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)

## Related Officers

- [company_representative](https://www.keypedia.com/people/davies-kochunni/3c6e7ba3-2651-4af8-9bf5-2ee7298d3169)
- [Consumer Safety Officer at FDA](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
- [Consumer Safety Officer at FDA](https://www.keypedia.com/people/joy-ann-p-matthias/129f51c0-e0ba-45a9-b4c3-921f0178351a)
- [Investigator ](https://www.keypedia.com/people/karen-l-kosar/6e58be60-f8e3-44f3-8218-8acdde249724)
- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)
